Loading company…
Velocity Pharmaceutical Development provides software applications that support pharmaceutical development for clients of all sizes.
Headquartered in San Francisco, US, Velocity Pharmaceutical Development is led by CEOs Bobby Singh and David Collier. The company has completed 2 deals, most recently in August 2013, when Tigercat Pharma, managed by Velocity, received an undisclosed amount of funding from Remeditex Ventures. It is listed at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in